Bio-Techne Corp.
Insider trading
Roger Lucas director
Shares sold: 100 Price:
Date: March 10$107.76–$107.81
Directly holds: 3,629
Communications Systems Inc.
Richard Primuth director
Shares purchased: 2,500 Price: $4.53
Date: March 15Directly holds: 15,487
CURTIS SAMPSON director
Shares purchased: 2,200 Price:
Date: March 15$4.45–$4.55
Directly holds: 1,083,037
Ecolab Inc.
Jerry Levin director
Shares sold: 748 Price: $124.49
Date: March 8Directly holds: 32,521
Famous Dave'S Of America Inc.
Patrick D. Walsh director
Shares sold: 35,000 Price: $4.52
Date: March 13Indirectly holds:
337,250
Graco Inc.
William Carroll director
Exercised options: 8,600 Price: $38.45
Shares sold: 3,552 Price: $93.17
Date: March 8Directly holds: 29,371
Eric Etchart director
Exercised options: 1,000 Price: $36.96
Shares sold: 393 Price: $94.40
Date: March 15Directly holds: 7,193
Martha A. Morfitt director
Exercised options: 3,600 Price: $40.66
Shares sold: 3,600 Price: $92.06–$92.61
Date: March 9Directly holds: 64,023
Hormel Foods Corp.
Terrell Crews director
Exercised options: 5,540 Price: $8.97
Date: March 9Directly holds: na
Nortech Systems Inc.
Kenneth Larson director
Shares purchased: 2,000 Price: $3.56
Date: March 14Directly holds: 7,000
Otter Tail Corp.
George Koeck general counsel
Shares sold: 4,000 Price: $36.30
Date: March 13Directly holds: 15,786
Patterson Companies
James Wiltz director
Shares sold: 5,000 Price: $44.52
Date: March 9Indirectly holds: 81,300
Pentair Plc
Ronald Lewis Merriman director
Exercised options: 10,000 Price: $34.18
Shares sold: 10,000 Price: $60.00
Date: March 10Directly holds: 16,640
Regis Corp.
Jim B. Lain chief operating officer
Shares sold: 3,200 Price: $12.21
Date: March 8Directly holds: 90,007
Tactile Systems Technology Inc.
Richard Nigon director
Shares purchased: 20,000 Price:
Date: March 13 $19.93–$20.50
Directly holds: 130,404
Unitedhealth Group
Robert Joseph Darretta director
Exercised options: 16,621 Price:
Date: March 15 $52.22–$54.62
Directly holds: na
about the writer
A spinoff company has been formed to produce a hormone supplement that reduces lung damage, but researchers still need to convince federal regulators of its safety and effectiveness.